• English
  • தமிழ்
  • বাংলা
  • മലയാളം
  • ગુજરાતી
  • हिंदी
  • मराठी
  • Business

The Financial Express

  • Whatsapp Whatsapp Link
  • Facebook Facebook Link
  • Twitter Twitter Link
  • Linkedin Linkedin Link
Google News Follow
Watchlist
  • Home
  • Business
  • Markets
  • Market Stats
  • Mutual Funds
  • Money
  • India News
  • Tech
  • US News
  • Shorts
  • ePaper
  • AI Stocks
  • MF Screener
  • Defence Stocks
  • Finance Stocks
  • Gold Rate
  • Silver Rate
  • Breakout Stocks
  • Home
  • Market
    • Stock Insights
    • Cryptocurrency
    • IPO News
    • Stock Market Quotes
    • Indices
    • Nifty 50
    • Sensex
    • Top Gainers
    • Top Losers
    • IPO Stats
  • Market Dashboard
  • Commodities
    • Gold Rate in India
    • Silver Rate in India
    • Petrol Rate in India
    • Diesel Rate in India
  • Opportunity Abroad
  • Money
    • Insurance
    • Income Tax
    • Mutual Funds News
    • MF Screener
  • Economy
  • Business
    • Brand Wagon
    • SME
    • Defence
    • Healthcare
  • Industry
    • Banking & Finance
  • India News
  • World News
  • Trending News
  • Jobs-Career
  • Infrastructure
    • Railways
    • Aviation
    • Roadways
  • Auto
  • Life
    • Lifestyle
    • Entertainment
    • Technology
    • Travel & Tourism
    • Science
  • Sports
  • Opinion
  • Multimedia
    • Photos
    • Web Stories
  • Events
  • ePaper
  • Today’s Paper
  • About us
  • PRIVACY POLICY
  • TERMS AND CONDITIONS
  • Contact Us

  1. Business News
  2. About
  3. pharmaceuticals

Page 2 of pharmaceuticals

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
Leena Gandhi Tewari, Chairperson at USV
‘Wellbeing Nutrition acquisition completes circle for USV’: Leena Gandhi Tewari, Chairperson at USV

USV Chairperson Leena Gandhi Tewari discusses the strategic rationale behind the ₹1,583-crore acquisition of Wellbeing Nutrition.

February 12, 2026 20:12 IST
Institutional giants bet Rs 350 crore on the 'DAVAINDIA' generic revolution. (AI generated image from Gemini)
Inside the Rs 350 crore bet: Why institutions doubled stakes in this loss-making pharma stock

Zota Health has been rapidly expanding, revenues are increasing multifold, but losses are deepening at the same time. Are institutional…

February 6, 2026 05:30 IST
Serum Institute awaits clarity on customs duty on SEZ sales to domestic market 

According to the announcement, SEZs will be allowed to sell in the DTA based on the proportion of goods exported.…

February 2, 2026 20:40 IST
Vijay Kedia’s new bet: Why the ‘SMILE’ investor is buying this crashed micro-cap Pharma stock. (Image Source: Canva)
Vijay Kedia’s new bet: Why he just bought this beaten down Rs 24 penny stock

Market Master Vijay Kedia just made his first big move for 2026, and it has already created a buzz in…

January 1, 2026 05:30 IST
Health Ministry Bans High-Dose Nimesulide: Popular 200mg Painkillers Prohibited with Immediate Effect
Govt bans popular painkiller drug Nimesulide; experts call the immediate ban unfair

The Indian government has banned oral Nimesulide formulations above 100mg, including tablets and syrups, citing serious liver safety concerns.

Updated: January 1, 2026 10:19 IST
Sun Pharma Lupin Torrent Intas GLP-1 obesity drugs India 2026
Rs 10,000-crore opportunity: Sun Pharma, Lupin, Torrent to lead 2026 weight-loss market as Ozempic patent expires

A revolution in India’s weight-loss market is coming. As Semaglutide’s patent ends in 2026, Sun Pharma, Lupin, Torrent, and Intas…

December 31, 2025 17:06 IST
A technical analysis chart of Ajanta Pharma stock showing the 17 percent upside potential toward the 3,145 target price set by Motilal Oswal.
Ajanta Pharma’s anti-obesity pivot: 4 reasons why Motilal Oswal sees 17% upside

Ajanta Pharma eyes new growth with anti-obesity pivot; Motilal Oswal sees 17% upside—read why you should consider this stock now.

December 31, 2025 11:34 IST
India's API powerhouses challenge China's dominance. (Image Source: Canva)
Beyond China: 3 Indian pharma stocks winning the global API war

APIs are a critical component in pharma manufacturing and nearly 65-70% of supplies in India come from China. The government…

December 20, 2025 05:30 IST
Corona Remedies Share Price, IPO GMP, Listing Live Updates:
Highlights: Corona Remedies sees a strong debut; lists at 38% premium to issue price

Corona Remedies listed at a 38% premium on NSE and BSE after Rs 655.37 crore IPO; check latest share price…

Updated: December 16, 2025 08:30 IST
Corona Remedies IPO Allotment Highlights
Highlights: Corona Remedies IPO listing soon – Check what GMP signals; GMP stands at 28.%

Corona Remedies IPO Allotment Live | Corona Remedies IPO Allotment Status Link, Listing Date, GMP Today, Refund, Demat Credit &…

Updated: December 12, 2025 13:28 IST
Rupee@90 The Gainers: IT, pharma and Rice exporters to benefit

Textiles exporters, however, continue to feel the pinch of tariffs.

Updated: December 4, 2025 10:51 IST
India's Drug Regulator Plans Stricter Rules for Generic Drug Launch, Pushing for Clinical Trials.
Govt invites fresh applications for the domestic production of bulk drugs under PLI scheme

In a notice, DoP said that it’s seeking applications from eight firms – four for each category – under the…

December 2, 2025 02:25 IST
The Trump effect: How Indian pharma’s ‘beyond US’ bet is finally paying off

Indian pharma exporters had for several months faced the rhetoric and threats from the Trump administration to impose tariffs on…

November 11, 2025 05:30 IST
Layoffs 2025: The job cuts follow similar moves by Oracle, Microsoft, and other companies that have recently let go of thousands of employees.
Novo Nordisk partners Emcure Pharma for weight loss medicine Poviztra in India

This collaboration combines Novo Nordisk’s innovation in GLP-1 therapies with Emcure’s marketing and distribution strengths to improve access to obesity…

November 10, 2025 23:17 IST
Two underdog pharma stocks exhibit high ROCE and near-zero debt. (This is an AI generated image)
Future pharma multibaggers? 2 underdog smallcaps with solid growth potential

2 lesser-known pharmaceutical companies are quietly recording slow but steady growth, and they are not shying away from giving back…

November 7, 2025 05:20 IST
Rubicon Research IPO, Rubicon Research IPO Day 3, Rubicon Research IPO GMP
Rubicon Research IPO opens today: GMP surges, valuation, should you subscribe? 5 ‘must know’ details

Rubicon Research IPO opens with strong GMP premium; subscribe by Oct 13 to participate in this key pharma offering. Apply…

October 9, 2025 11:00 IST
Trump built a tariff wall, Indian pharma found a European gate

Large Indian generic exporters are expanding their presence in European markets via a spate of acquisitions in that region, at…

September 30, 2025 05:00 IST
ICICI Lombard Dividend 2025: Check record date, eligibility, and other key details
Dividend stocks: Glenmark Pharma only stock to trade ex-dividend this week

Dividend stocks this week, September 28: Glenmark Pharma trades ex-dividend on Oct 3; watch for interim Rs 2.5 payout. Check…

September 28, 2025 07:00 IST
  • « Prev
  • Next »

Related News

Jefferies Buy ratings on Swiggy Adani Energy Solutions and Britannia stocks
3 ‘Buy’ recommendations by Jefferies, with 16% to 49% upside potential
Image shows Bhuvneshwar Kumar his net worth, money, investments and portfolio
From Swing King to Businessman: How a Meerut Boy Built a ₹75-Crore Legacy Beyond Cricket
Delhi Metro, Delhi Metro Phase 5B, New corridor in Delhi Metro, Metro, North West Delhi metro corridor, new metro corridor to link Keshavpuram and Rohini Sector 34
Delhi Metro Phase V(B): New metro corridor to link Keshavpuram and Rohini Sector 34 – Here’s what commuters can expect
Delhi Metro, Metro, Delhi Metro Phase 5B, new metro corridor, Dhansa Bus Stand and Nangloi corridor
West Delhi to get major metro boost: New corridor between Dhansa Bus Stand and Nangloi to cut traffic and travel time
Iran, US-Israel war LIVE updates
Iran, US-Israel war LIVE updates: Trump flies to Beijing as Iran talks collapse — ‘deal or decimation’ ultimatum hangs over the Gulf
shorts
Kia bets on battery subscription model to boost EV sales
Kia bets on battery subscription model to boost EV sales
1 hr ago

Kia India introduces BaaS financing for the MY26 Kia Carens Clavis EV, the first EV in India to offer this. The programme allows separate financing for the vehicle body and battery, reducing upfront costs. Two battery pack options and cosmetic updates are available. Multiple lenders partner to offer flexible vehicle financing of up to 60 months.

View all shorts

Trending Topics

defence stocks
Gold rate today
Silver rate today
AI stocks
mutual funds
semiconductor stocks

Top Categories
  • Market
  • India News
  • Stock Insights
  • Money
  • Opportunities Abroad
  • World News
  • Latest News
  • Technology
  • ITR Guide
  • Money Insights
Stock Screeners
  • Stock Screener
  • Break Out Stocks
  • Defence Stocks
  • Consistently Growing Stocks
  • Low Price Blue Chip Stocks
Top NSE/BSE Companies Share Price
  • Tata Motors share price
  • Tata Steel share price
  • State Bank Of India share price
  • HDFC Bank share price
  • Infosys share price
  • ITC share price
  • Wipro share price
  • NTPC share price
  • ongc share price
  • Adani Enterprises share price
  • Adani Ports and Special Economic Zone share price
  • Bharat Petroleum Corporation share price
  • Coal India share price
  • Bajaj Finance share price
  • ICICI Bank share price
  • Titan Company share price
  • Larsen & Toubro share price
  • Power Grid Corporation Of India share price
  • Asian Paints share price
Gold Price in Top Metro Cities
  • Gold Rate Today
  • Gold Rate in Dubai
  • Gold Rate in Chennai
  • Gold Rate in Kerala
  • Gold Rate in Hyderabad
  • Gold Rate in Bangalore
  • Gold Rate in Mumbai
  • Gold Rate in Noida
  • Gold Price in Delhi
  • Gold Price in Ahmedabad
  • Gold Price in Kolkata
Latest News
  • India’s first semi high-speed railway gets Cabinet nod; Ahmedabad-Dholera line to cost Rs 20,667 crore
  • SEBI mulls specialised distributors to expand debt market
  • Centre eyes year-end rollout of sovereign-backed financing support for private e-buses, trucks
  • No pattern in F-1 visa approvals or rejections: A first-hand look at what happens inside a US visa consulate
  • Amul hikes milk prices by Rs 2 per litre, effective from May 14 across India
Follow Us
  • Facebook Facebook Link
  • Twitter Twitter Link
  • Linkedin Linkedin Link
Download Apps
  • Play_stor Play_stor Link
  • Apple_stor Apple_stor Link
Express Group
  • INDIAN EXPRESS GROUP
  • The Indian Express
  • Loksatta
  • Jansatta
  • Inuth
  • Ramnath Goenka Awards
  • IE Tamil
  • IE Malayalam
  • IE Bangla
  • IE Gujarati
  • IE Education
  • This website follows the DNPA’s code of conduct
Quick Links
  • T&C
  • Privacy Policy
  • CONTACT US
  • About Us
Copyright © 2026 The Indian Express [P] Ltd. All Rights Reserved
Market Pulse